Compare NEOG & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | DEI |
|---|---|---|
| Founded | 1981 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1995 | 2006 |
| Metric | NEOG | DEI |
|---|---|---|
| Price | $9.13 | $11.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 8 |
| Target Price | $10.67 | ★ $12.94 |
| AVG Volume (30 Days) | 2.1M | ★ 2.6M |
| Earning Date | 04-09-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.06% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | $894,661,000.00 | ★ $1,003,982,000.00 |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | N/A | $2.35 |
| P/E Ratio | $465.50 | ★ N/A |
| Revenue Growth | N/A | ★ 1.77 |
| 52 Week Low | $4.56 | $9.04 |
| 52 Week High | $11.43 | $16.94 |
| Indicator | NEOG | DEI |
|---|---|---|
| Relative Strength Index (RSI) | 50.61 | 48.72 |
| Support Level | $8.86 | $11.13 |
| Resistance Level | $9.49 | $12.58 |
| Average True Range (ATR) | 0.31 | 0.37 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 56.25 | 20.59 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.